Literature DB >> 21957010

Cap and cap-binding proteins in the control of gene expression.

Ivan Topisirovic1, Yuri V Svitkin, Nahum Sonenberg, Aaron J Shatkin.   

Abstract

The 5' mRNA cap structure is essential for efficient gene expression from yeast to human. It plays a critical role in all aspects of the life cycle of an mRNA molecule. Capping occurs co-transcriptionally on the nascent pre-mRNA as it emerges from the RNA exit channel of RNA polymerase II. The cap structure protects mRNAs from degradation by exonucleases and promotes transcription, polyadenylation, splicing, and nuclear export of mRNA and U-rich, capped snRNAs. In addition, the cap structure is required for the optimal translation of the vast majority of cellular mRNAs, and it also plays a prominent role in the expression of eukaryotic, viral, and parasite mRNAs. Cap-binding proteins specifically bind to the cap structure and mediate its functions in the cell. Two major cellular cap-binding proteins have been described to date: eukaryotic translation initiation factor 4E (eIF4E) in the cytoplasm and nuclear cap binding complex (nCBC), a nuclear complex consisting of a cap-binding subunit cap-binding protein 20 (CBP 20) and an auxiliary protein cap-binding protein 80 (CBP 80). nCBC plays an important role in various aspects of nuclear mRNA metabolism such as pre-mRNA splicing and nuclear export, whereas eIF4E acts primarily as a facilitator of mRNA translation. In this review, we highlight recent findings on the role of the cap structure and cap-binding proteins in the regulation of gene expression. We also describe emerging regulatory pathways that control mRNA capping and cap-binding proteins in the cell.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21957010     DOI: 10.1002/wrna.52

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev RNA        ISSN: 1757-7004            Impact factor:   9.957


  167 in total

1.  Structure of the guanylyltransferase domain of human mRNA capping enzyme.

Authors:  Chun Chu; Kalyan Das; James R Tyminski; Joseph D Bauman; Rongjin Guan; Weihua Qiu; Gaetano T Montelione; Eddy Arnold; Aaron J Shatkin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-02       Impact factor: 11.205

2.  Interfering with tumor pathways that augment viral oncolysis.

Authors:  John C Bell
Journal:  Mol Ther       Date:  2011-12       Impact factor: 11.454

Review 3.  Translation initiation of the HIV-1 mRNA.

Authors:  Théophile Ohlmann; Chloé Mengardi; Marcelo López-Lastra
Journal:  Translation (Austin)       Date:  2014-10-31

4.  mRNAs biotinylated within the 5' cap and protected against decapping: new tools to capture RNA-protein complexes.

Authors:  Sylwia Bednarek; Vanesa Madan; Pawel J Sikorski; Ralf Bartenschlager; Joanna Kowalska; Jacek Jemielity
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-11-05       Impact factor: 6.237

Review 5.  RNA polymerase II transcription elongation control.

Authors:  Jiannan Guo; David H Price
Journal:  Chem Rev       Date:  2013-08-06       Impact factor: 60.622

6.  Broad and adaptable RNA structure recognition by the human interferon-induced tetratricopeptide repeat protein IFIT5.

Authors:  George E Katibah; Yidan Qin; David J Sidote; Jun Yao; Alan M Lambowitz; Kathleen Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

Review 7.  LARP1 on TOP of ribosome production.

Authors:  Bruno D Fonseca; Roni M Lahr; Christian K Damgaard; Tommy Alain; Andrea J Berman
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-05-02       Impact factor: 9.957

Review 8.  Eukaryotic RNA 5'-End NAD+ Capping and DeNADding.

Authors:  Megerditch Kiledjian
Journal:  Trends Cell Biol       Date:  2018-03-12       Impact factor: 20.808

9.  Judge, jury, and executioner: DXO functions as a decapping enzyme and exoribonuclease in pre-mRNA quality control.

Authors:  Jeffrey S Mugridge; John D Gross
Journal:  Mol Cell       Date:  2013-04-11       Impact factor: 17.970

10.  CAP-MAP: cap analysis protocol with minimal analyte processing, a rapid and sensitive approach to analysing mRNA cap structures.

Authors:  Alison Galloway; Abdelmadjid Atrih; Renata Grzela; Edward Darzynkiewicz; Michael A J Ferguson; Victoria H Cowling
Journal:  Open Biol       Date:  2020-02-26       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.